Business Context and Reporting Period
This Form 8-K Current Report was filed by Marchex, Inc. on April 17, 2019. The filing discloses the entry into a material definitive agreement regarding executive compensation and the appointment of certain officers.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on equity compensation arrangements.
Material Changes and Executive Compensation
On April 17, 2019, the Compensation Committee approved the following equity awards for Michael Arends under the 2012 Stock Incentive Plan:
- Stock Options: 34,000 shares of Class B Common Stock with an exercise price of $5.05 per share (closing price on the Grant Date).
- Restricted Stock: 34,000 shares of Class B Common Stock.
Vesting Schedule:
- Options: 25% vests on the first annual anniversary; the remainder vests quarterly over the following three years.
- Restricted Stock: 25% vests on each of the first, second, third, and fourth annual anniversaries.
All awards are subject to continued employment.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the standard vesting conditions tied to employment.
Key Facts for Investor Verification
- Verify the total number of shares authorized under the 2012 Stock Incentive Plan to assess remaining capacity for future grants.
- Confirm Michael Arends' current role and tenure to evaluate the strategic intent of this compensation package.
- Review the company's stock price history relative to the $5.05 exercise price to determine the intrinsic value of the options.
- Check subsequent filings for any changes to the vesting schedule or employment status of the recipient.